Bayer shares jump on recommendation for Xarelto - Reuters





<img alt="" height="1" width="1"><img src=http://nt3.ggpht.com/news?imgefp=V1DWhbtZSIQJ&imgurl=www.enews20.com/content/news/news_17051.jpg width=80 height=60 alt="" border=1>

Enews 2.0
Bayer shares jump on recommendation for Xarelto

Reuters

FRANKFURT, March 20 (Reuters) - Bayer AG (BAYG.DE) shares jumped as much as 9 percent on Friday, following a green light for the German company's key new drug Xarelto from a US panel, putting it on track to win approval in its largest market.

Bayer Shares Soar on US Panel Backing for Xarelto Bloomberg

FDA Panel Gives Nod to Alternative to Warfarin New York Times

CNNMoney.com - Forbes - The Associated Press - RTT Newsall 257 news articles